Liquidia Corporation
NasdaqCM:LQDA
Sector
Industries
Location
Market Cap
USD 2.35 B
Share Price
USD 27.30
Avg Daily Volume
2,846,390
Change (1 day)
-0.18%
Change (1 year)
173.55%
Change (YTD)
132.14%
Liquidia Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2025: -640.64%
Liquidia Corporation EBITDA Margin is -640.64% for the Trailing 12 Months (TTM) ending June 30, 2025, a -5.88% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
-
Liquidia Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was -680.69%, a 176.56% change year over year.
-
Liquidia Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was -246.12%.
StockViz
Competitors
Eli Lilly and Company
USD 709.82
LLY
+4.38
0.62%
AbbVie Inc.
USD 209.50
ABBV
+0.35
0.17%
Roche Holding AG
USD 339.30
RO.SW
-2.14
-0.63%
Novartis AG
USD 127.19
NOVN.SW
-0.09
-0.07%
Novo Nordisk A/S
USD 55.23
NOVO-B.CO
+1.42
2.64%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Abbott Laboratories
USD 132.00
ABT
-0.44
-0.33%
Merck & Co., Inc.
USD 86.08
MRK
+1.42
1.68%
Thermo Fisher Scientific Inc.
USD 483.76
TMO
-11.05
-2.23%
Amgen Inc.
USD 295.76
AMGN
-0.69
-0.23%
Pfizer Inc.
USD 25.74
PFE
+0.36
1.42%
Gilead Sciences, Inc.
USD 116.14
GILD
-2.59
-2.18%
Sanofi
USD 101.52
SAN.PA
+0.13
0.13%
Vertex Pharmaceuticals Incorporated
USD 397.46
VRTX
+3.10
0.79%
Bristol-Myers Squibb Company
USD 48.43
BMY
+0.17
0.35%
Key Data
| Date | EBITDA Margin | Net Income Margin | EBT Margin | Operating Income Margin |
|---|
Competitors
Eli Lilly and Company
USD 709.82
LLY
+4.38
0.62%
AbbVie Inc.
USD 209.50
ABBV
+0.35
0.17%
Roche Holding AG
USD 339.30
RO.SW
-2.14
-0.63%
Novartis AG
USD 127.19
NOVN.SW
-0.09
-0.07%
Novo Nordisk A/S
USD 55.23
NOVO-B.CO
+1.42
2.64%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Abbott Laboratories
USD 132.00
ABT
-0.44
-0.33%
Merck & Co., Inc.
USD 86.08
MRK
+1.42
1.68%
Thermo Fisher Scientific Inc.
USD 483.76
TMO
-11.05
-2.23%
Amgen Inc.
USD 295.76
AMGN
-0.69
-0.23%
Pfizer Inc.
USD 25.74
PFE
+0.36
1.42%
Gilead Sciences, Inc.
USD 116.14
GILD
-2.59
-2.18%
Sanofi
USD 101.52
SAN.PA
+0.13
0.13%
Vertex Pharmaceuticals Incorporated
USD 397.46
VRTX
+3.10
0.79%
Bristol-Myers Squibb Company
USD 48.43
BMY
+0.17
0.35%